Abstract:[Objective] To evaluate the value of application on BALB/c mice bearing liver cancer H22 imaging with hypoxia-avid agent ~(99)Tc~m HL91.[Methods] One mg HL91 was dissolved in 2 mL sterile sodium pertechnetate solution containing 1110 MBq(30mCi) ~(99)Tc~m.A stannous DTPA kit was reconstituted with 10 mL saline,an aliquot of 50 μL was removed and added to the vial containing HL91 and pertechnetate.After 10 minutes at room temperature,the radiochemical purity of the preparation of ~(99)Tc~m-HL91 was determined before use by paper and thin-layer chromatography,and exceeded 95%.There are 13 BALB/c mice bearing liver cancer HCa-F in the research.After anaesthesia,HL91(37 MBq) was injected intravenously.Three mice were underwent whole body planar static imaging after 2 h injection of ~(99)Tc~m-HL91,and five mice after 4 h,other five mice after 6h were also performed the same whole body planar imaging.Four regions of interest(ROI) were set on the tumor,head,abdomen and the thorax opposing to the thorax near tumor in the imaging.The radioactivity in the ROIs was measured.The tumor-to-normal tissue ratios of tumor to head,abdomen and thorax were calculated.[Results] All of the tumor were found ~(99)Tc~m-HL91 uptake.The uptake of HL91 in the tumor reached a peak at 4 h and then gradually decreased.After 6h postinjection of ~(99)Tc~m-HL91,the radioactivity of tumor was descended slightly.HL91 accumulated to highly levels in the hypoxic area than in other tissues except for abdomen.The tumor-to-normal tissue ratios of tumor to head,thorax and abdomen were 4.26±2.29,3.40±0.91,0.41±0.19,respectively.The ratio of T/NT at 4 h or 6 h is higher than that of 2 h,there were significant difference(P0.01).The T/NT continued increase until 6 h postinjection of ~(99)Tc~m-HL91.However,The radioactivity of abdomen was higher than tumor.[Conclusions] High uptake of ~(99)Tc~m-HL91 in the tumor of BALB/c mice bearing liver cancer H22(H-2),and the clearance rate is slower.High T/NT can be obtained after 4 h injection of ~(99)Tc~m-HL91.T/NT is a very important index in tumor hypoxic imaging.

Preliminary Clinical Study on Distinguishing Breast Tumor with 99tcm -HL91 Imaging

Value of 99Tcm-Mibi Imaging on Differentiation and Diagnosis of Benign and Malignant Breast Lesions

Clinical study of 99Tcm-HL91 in diagnosis of pulmonary neoplasms

~(99)Tc~m-Mibi Scintimammography in the Evaluation of the Benign and Malignant Breast Tumor and Axillary Lymph Node Metastases

Comparison of 99Tcm-HL91 and 99Tcm-MIBI tumor positive imaging in diagnosis of lung neoplasms

Clinical Research on Lung Cancer Imaging with 99Tcm -HL91 SPECT

The Evaluation of 99Tcm-3Prgd2 Integrin Receptor Imaging in the Differential Diagnosis in Benign and Malignant Breast Lesions Comparision with Ultrasound

Clinical Significance of 99Mtc-Hl91 Hypoxic Imaging and 99Mtc-Mibi Imaging in Diagnosis of Lung Cancer

Evaluation of 99Tcm-3Prgd2 Integrin Receptor Imaging in Qualitative Diagnosis of Breast Cancer and Its Comparison with Mammography

Pilot Study on the Value of ~(99m) Tc-HL91 SPECT Hypoxia Imaging in Diagnosis of Patients with Nasopharyngeal Carcinoma

The Diagnostic Value of 99Tcm-Hl91 Hypoxia Imaging in Primary and Metastatic Lung Cancer

Diagnostic Value by 99mTc-MIBI Semi-quantitative Imaging for Lung Neoplasms

An Experimental Study on Mice Bearing Liver Cancer Imaging with ~(99)Tc~m-Hl91

Evaluation of Tc-99m-3prgd2 Integrin Receptor Imaging in the Differential Diagnosis of Breast Lesions and Comparison with Mammography

The Clinical Usefulness of 99Mtc-Tetrofosmin Scintigraphy in the Diagnosis of Lung Neoplasmas and Mediastinal Lymphoid Node Involvement

[Preliminary Clinical Application of 99Tcm-Hynic-toc Imaging in Somatostatin Receptor-Positive Tumors].

99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.

99Mtc-3P4-rgd2 Scintimammography in the Assessment of Breast Lesions: Comparative Study with 99Mtc-Mibi

The Application of 99Mtc-Hl91 Hypoxic Imaging in Detecting Radiotherapy Response in 30 Patients with Nasopharyngeal Carcinoma

The Relationship Between ~(99)Tc~m-MIBI Imaging of Breast Cancer and the Expression of P-gp,GST-π and Bcl-2

Complement of 99Mtc-Octreotide Scintimammography to Mammography in Evaluating Breast Cancers